SCN5A and myotonic dystrophy type 1: The results indicate a role for decreased Scn5a expression in DM1 cardiac pathogenesis, given that SCN5A loss of function in humans causes a variety of cardiac defects and that Scn5a+/– mice show heart conduction defects (45–48).